Search Results - Bingfeng Lu
- Showing 1 - 4 results of 4
-
1
-
2
A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation by Xi Chen, Xin Liu, Qian-hui Li, Bingfeng Lu, Bumin Xie, Yu‐meng Ji, Yang Zhao
Published 2023Artigo -
3
Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer by Bingfeng Lu, Shuo Chen, Xue Guan, Xi Chen, Yuping Du, Jing Yuan, Jielin Wang, Qinghua Wu, Lingfeng Zhou, Xiangchun Huang, Yang Zhao
Published 2025Artigo -
4
SNORA70E promotes the occurrence and development of ovarian cancer through pseudouridylation modification of <i>RAP1B</i> and alternative splicing of <i>PARPBP</i> by Shuo Chen, Qianhui Li, Xi Chen, Hai‐Juan Bao, Wu Wu, Fan Shen, Bingfeng Lu, Ru‐Qi Jiang, Zhi‐hong Zong, Yang Zhao
Published 2022Artigo
Search Tools:
Related Subjects
Biology
Cancer
Cancer research
Gene
Genetics
Cell biology
Long non-coding RNA
Ovarian cancer
RNA
Signal transduction
Small nucleolar RNA
Beta-catenin
Carcinogenesis
Catenin
Cell cycle
Cell growth
Computational biology
Endometrial cancer
Enhancer
FOXM1
Gene expression
Gene silencing
Internal medicine
Medicine
Molecular biology
Neuroscience
Nucleolus
Nucleus
Oncology
Organoid